At the very least, you should evaluate your mo st frequently submitted CPT codes and their RVUs whenever you review your fee schedule, particularly if you are receiving nearly 100% of your fee . If you do not, you will not know how much money yo u are losing.
and $8 .16 on two of the via ls-95 165(A) and 95165(B), respectively . Converse ly, the practice's fee exceeds the Medicare allowable for vials 95 I65(C) and 95165 (D) .
At the very least, you should evaluate your mo st frequently submitted CPT codes and their RVUs whenever you review your fee schedule, particularly if you are receiving nearly 100% of your fee . If you do not, you will not know how much money yo u are losing.
How freq uently do you review your fee sched ules? If you do an annual review, do you update the relative value units (RVUs) as they pertain to your fees? You should instruct your staff to review the fees for your most frequently submitted CPT codes and to compare the amounts of your submissions with the amounts that you have actually been paid . Those fees that are being paid at or close to 100% should be eva lua ted closely .
You can kee p track of this by crea ting a specific sprea dsheet. The spreadsheet data shown in figure I reveal that the Medicare allowable is higher than the fee billed by the practice. Thi s practice is losing $ 1.5 1/unit every time it bill s for a vial of allergy extract.
Anot her spreadsheet can allow you to further analyze the amo unt of reimbursement the practice is losing ( figure  2 ). In the case illustrated here, the prac tice is losing $18 . 12 
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